相关实验视频

Updated: Jan 30, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

苏尔福拉作为甲基胺补充剂治疗注意力缺陷/多动障碍:一项随机,双盲,安慰剂控制的试验

Farnaz Ghannadi¹, Ahmad Shamabadi¹, Mohammad Saleh Talebinejad¹

¹Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Clinical neuropharmacology

|January 28, 2026

概括

苏尔福拉,当添加到甲基酸盐,显著改善了儿童注意力缺陷/多动症 (ADHD) 症状. 这种组合疗法被发现是安全的,耐受性很好,为管理ADHD提供了一个有前途的新方法.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
儿科儿科儿科

背景情况:

注意缺陷/多动障碍 (ADHD) 存在重大治疗挑战.
需要新的治疗策略来解决当前ADHD治疗的局限性.
苏尔福拉具有神经保护性,抗炎性和抗氧化性质,表明潜在的治疗益处.

研究的目的:

调查硫福拉作为儿童多动症辅助疗法的疗效和安全性.
评估硫福拉对ADHD症状的影响,包括注意力不集中和过度活跃-冲动性.

主要方法:

这是一项随机对照试验,涉及70名年龄在6-11岁的ADHD儿童.
参与者接受了甲基化物加上硫黄 (30毫克/天) 或安慰剂8周.
在基线,第4周和第8周,老师和家长使用ADHD评分表 (ADHD-RS) 评估了ADHD症状.

主要成果:

与安慰剂组相比,在硫福拉组中观察到ADHD-RS总,注意力缺失和过度活跃-冲动性得分的显著降低.
硫福拉辅助疗法获得了更高的治疗反应率,强大的改善和缓解.
副作用的发生频率在硫福拉和安慰剂组之间是可比的,这表明耐受性良好.

结论:

在甲基化物治疗中添加硫福拉,对患有ADHD的儿童有显著的益处.
组合疗法有效地改善了注意力不集中,过度活跃-冲动性和ADHD整体症状.
苏尔福拉被发现是对甲基酸的安全且耐受良好的补充剂,用于儿科ADHD治疗.

关键词:

菜和西兰花是不同的.药物治疗的组合药物治疗.多巴胺是多巴胺的一种.神经免疫调节是一种神经免疫调节.随机对照试验是随机对照试验.

更多相关视频

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

相关概念视频

Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...